Yue Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yue Jiang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- An Song
Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Translational Medicine Center, State Key Laboratory of Complex Severe and Rare Diseases, National Health Commission Key Laboratory of Endocrinology, Beijing 100730, China
4 shared publications - Mei Li
Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 100730
4 shared publications - Ou Wang
Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 100730
4 shared publications - Weibo Xia
Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 100730
4 shared publications - Xiaoping Xing
Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
4 shared publications - Min Nie
NHC Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730
3 shared publications
Latest Publications
- Open Access
- 27 May 2026
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 11 (1) , e95855
Age- and Sex-Specific Distribution of the Triglyceride-Glucose Index in a Large Chinese Population: Cross-Sectional Study
Background: The triglyceride-glucose (TyG) index has demonstrated promising predictive capability in clinical studies, but its distribution characteristics across different age and sex groups in the Chinese population have not been fully characterized. Objective: This study aimed to describe the population-based distribution of the TyG index. Methods: A total of 4621 participants aged 20‐80 years from the China National Health Survey were included in this study. The TyG index was calculated from fasting blood glucose and triglycerides. The age- and sex-specific distribution values of the TyG index were obtained using the percentiles method. Results: Males had higher BMI (23.32, SD 2.63 vs 22.72, SD 2.60 kg/m 2 ), triglyceride (133.78, SD 78.07 vs 111.58, SD 61.18 mg/dL), fasting glucose (97.05, SD 11.95 vs 94.34, SD 10.46 mg/dL), and TyG index values (8.63, SD 0.54 vs 8.45, SD 0.50) than females. The TyG index of males reached its peak value at approximately 40 years of age. The lower limit percentile values for females exceeded that of males around age 50. After the age of 60, the upper limit of the distribution values in females was higher than in males. Conclusions: This study characterized the age- and sex-specific distribution of the TyG index among Chinese adults aged 20‐80 years. The results of this study contribute to a more precise assessment of glucolipid metabolism.
- 27 May 2026
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 11 (1) , e95855
Open AccessAge- and Sex-Specific Distribution of the Triglyceride-Glucose Index in a Large Chinese Population: Cross-Sectional Study
Background: The triglyceride-glucose (TyG) index has demonstrated promising predictive capability in clinical studies, but its distribution characteristics across different age and sex groups in the Chinese population have not been fully characterized. Objective: This study aimed to describe the population-based distribution of the TyG index. Methods: A total of 4621 participants aged 20‐80 years from the China National Health Survey were included in this study. The TyG index was calculated from fasting blood glucose and triglycerides. The age- and sex-specific distribution values of the TyG index were obtained using the percentiles method. Results: Males had higher BMI (23.32, SD 2.63 vs 22.72, SD 2.60 kg/m 2 ), triglyceride (133.78, SD 78.07 vs 111.58, SD 61.18 mg/dL), fasting glucose (97.05, SD 11.95 vs 94.34, SD 10.46 mg/dL), and TyG index values (8.63, SD 0.54 vs 8.45, SD 0.50) than females. The TyG index of males reached its peak value at approximately 40 years of age. The lower limit percentile values for females exceeded that of males around age 50. After the age of 60, the upper limit of the distribution values in females was higher than in males. Conclusions: This study characterized the age- and sex-specific distribution of the TyG index among Chinese adults aged 20‐80 years. The results of this study contribute to a more precise assessment of glucolipid metabolism.
- 1 April 2026
- Published by Springer Nature in Endocrine
- Vol. 91 (1)
Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study
- 1 April 2026
- Published by Springer Nature in Endocrine
- Vol. 91 (1)
Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study
- 9 March 2026
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (8) , 1-13
Clinical characteristics of chinese patients with autosomal dominant hypocalcemia type 1: a single-center study
- 9 March 2026
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (8) , 1-13
Clinical characteristics of chinese patients with autosomal dominant hypocalcemia type 1: a single-center study
- Open Access
- 13 March 2025
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 11 (1) , 22-28
Two novel rare variants in the PTH gene found in patients with hypoparathyroidism
- 13 March 2025
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 11 (1) , 22-28
Open AccessTwo novel rare variants in the PTH gene found in patients with hypoparathyroidism
- 31 July 2023
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 38 (9) , 1322-1333
Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single‐center study
Primary hyperparathyroidism (PHPT) includes sporadic PHPT and hereditary PHPT. However, until now, there have been no exact data on the proportion and composition of hereditary PHPT in the Chinese PHPT population. This study aimed to clarify the proportion and composition of hereditary PHPT in patients at a large academic center in Beijing, China, and to analyze genotype–phenotype characteristics. A total of 394 newly diagnosed Han PHPT patients who consented to genetic screening were enrolled. Targeted next‐generation sequencing (T‐NGS) (including for MEN1, RET, CDKN1B, CaSR, HRPT2/CDC73, GNA11, AP2S1, GCM2), combined with MEN1‐multiplex ligation‐dependent probe amplification (MLPA) and CDC73‐MLPA, was used for genetic screening. Diagnosis of hereditary PHPT was based on clinical manifestations, family history, and genetic screening. Thirty‐seven pathogenic (P)/likely pathogenic (LP) variants were detected in 41 patients via T‐NGS, and three patients carried long‐range deletions of MEN1 or CDC73 detected by MLPA, with a variant detection rate of 11.2% (44/394). In total, 30 patients were clinically diagnosed with MEN1. Combined with genetic and clinical screening, the rate of hereditary PHPT in this study was 18.8% (74/394). For purposes of comparison, the rate of unequivocal nonhereditary PHPT was 66.5% (262/394); 14.7% (58/394) did not exhibit the clinical features of hereditary PHPT but carried variants of uncertain clinical significance and so could not be clearly categorized. Both the age at hospital visit (43.6 ± 14.0 versus 53.7 ± 14.9 years) and age at onset (35.4 ± 13.8 versus 50.6 ± 14.8 years) in the hereditary group (n = 74) were significantly lower than those in the nonhereditary group (n = 262). Higher levels of ionized calcium and serum β‐CTX were observed in the hereditary group; proportions of parathyroid hyperplasia and multigland involvement were also higher. In addition to multigland disease and positive family history, it is recommended that patients with an age of onset less than 38 should be screened for hereditary forms. © 2023 American Society for Bone and Mineral Research (ASBMR).
- 31 July 2023
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 38 (9) , 1322-1333
Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single‐center study
Primary hyperparathyroidism (PHPT) includes sporadic PHPT and hereditary PHPT. However, until now, there have been no exact data on the proportion and composition of hereditary PHPT in the Chinese PHPT population. This study aimed to clarify the proportion and composition of hereditary PHPT in patients at a large academic center in Beijing, China, and to analyze genotype–phenotype characteristics. A total of 394 newly diagnosed Han PHPT patients who consented to genetic screening were enrolled. Targeted next‐generation sequencing (T‐NGS) (including for MEN1, RET, CDKN1B, CaSR, HRPT2/CDC73, GNA11, AP2S1, GCM2), combined with MEN1‐multiplex ligation‐dependent probe amplification (MLPA) and CDC73‐MLPA, was used for genetic screening. Diagnosis of hereditary PHPT was based on clinical manifestations, family history, and genetic screening. Thirty‐seven pathogenic (P)/likely pathogenic (LP) variants were detected in 41 patients via T‐NGS, and three patients carried long‐range deletions of MEN1 or CDC73 detected by MLPA, with a variant detection rate of 11.2% (44/394). In total, 30 patients were clinically diagnosed with MEN1. Combined with genetic and clinical screening, the rate of hereditary PHPT in this study was 18.8% (74/394). For purposes of comparison, the rate of unequivocal nonhereditary PHPT was 66.5% (262/394); 14.7% (58/394) did not exhibit the clinical features of hereditary PHPT but carried variants of uncertain clinical significance and so could not be clearly categorized. Both the age at hospital visit (43.6 ± 14.0 versus 53.7 ± 14.9 years) and age at onset (35.4 ± 13.8 versus 50.6 ± 14.8 years) in the hereditary group (n = 74) were significantly lower than those in the nonhereditary group (n = 262). Higher levels of ionized calcium and serum β‐CTX were observed in the hereditary group; proportions of parathyroid hyperplasia and multigland involvement were also higher. In addition to multigland disease and positive family history, it is recommended that patients with an age of onset less than 38 should be screened for hereditary forms. © 2023 American Society for Bone and Mineral Research (ASBMR).